© 2022 WSIU Public Radio
WSIU Public Broadcasting
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
In a large study, experimental drug lecanemab was able to slow down Alzheimer's, but not stop it. Some researchers think the drug will become the first to help many patients; others have questions.
Cemile Bingol
/
Getty Images
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.